Ce contenu est uniquement disponible en anglais
RBM Private Sector Constituency (PSC)
The Private Sector Constituency of the Roll Back Malaria Partnership (RBM) is broadly defined as the community of businesses with a recognized role or interest in malaria control.
The Contributions of the Private Sector to the RBM Partnership
There are several crucial areas where the private sector can contribute to the RBM Partnership.
- First, the private sector possesses a breadth of expertise and implementation skills – including delivering products and programmes in the developing world. These skills include innovation, production and distribution at global and country levels. Additionally, many enterprises within the private sector have global reach. Companies deliver products, communicate to diverse customers and provide a myriad of services to the most remote places. There are many examples of successful malaria control programmes implemented by companies in partnership with governments, particularly in Africa: they provide support, treatment and care to millions of employees and citizens that would otherwise not have access to curative services.
- Second, the private sector has a particularly important role to play in ensuring the supply and efficient distribution of drugs, diagnostics, LLIN's and other interventions against malaria. In addition, a major objective of the Partnership is to develop "new tools" – novel effective drugs, diagnostics, vector control and vaccines to replace the decades-old existing tools and anticipate the apparition of resistance – with the aim of achieving better malaria control toward elimination.
- Finally, the private sector can bring the "business mindset" to the RBM Partnership, with its emphasis on good management practices and tangible results.
Members of the PSC
Members of the PSC come from a variety of industries that are relevant to the goals of the RBM Partnership. These include companies that develop related medical products, drugs and commodities (such as diagnostic tools, LLIN's, IRS), companies with expertise in implementing malaria programmes in affected countries (for example mining, energy and con-struction companies) as well as those companies that have a broad range of skills and experience pertinent to current issues in malaria such as advocacy, procurement and distribution (for example media/communications, logistics and consumer goods companies).
The structure of the PSC
The Private Sector Constituency (PSC) is a broad group of private sector companies that are interested in malaria activities. PSC members get informed about outcomes of important RBM meetings, receive information relevant to the private sector, and are welcome to join RBM Working Groups after signing the RBM Declaration of Interest Form.
View also RBM Conflict of Interest Policy and Procedure.
The PSC is represented by the Private Sector Delegation (PSD), a subset of the PSC, which consists of corporate representatives who have signed the PSC Conflict of Interest (COI) Policy. The PSD is committed to upholding the highest ethical standards in all of its engagements within the RBM Partnership. Only PSD members have the mandate to represent the Private Sector in the RBM Partnership and may serve as formal representatives in the RBM mechanisms [Board, Executive Committee (EC), Task Forces and Working Groups (WG)].
Click the following link to see current members of the PSD.
The PSD is represented by the Private Sector Representatives (PSR), which include the two official Board Members, their Alternates and the Focal Point (FP). PSR are members of the PSD and have signed the PSC COI Policy. The Board and Alternate seats are elected by the PSD for two-year terms. Since May 2010, the PSC Board members of the RBM Partnership are Mikkel Vestergaard, CEO, Vestergaard Frandsen; and Rebecca Stevens, Director of Public Affairs, Malaria Initiatives – Novartis International AG. Alternate RBM Board Members are Hans Berg, Senior Health Advisor, Shell International B.V. and Jon Pender, Director Government Affairs, GlaxoSmithKline (GSK).
The International Business Leaders Forum (IBLF) hosts the Focal Point (FP) for the PSC and helps coordinate private sector involvement in the RBM Partnership. This function is funded by PSD members through a small annual membership fee.
For further information on the PSC/PSD as well as the RBM Partnership and its Working Groups, please contact: Kathrin Bauer, Programme Manager at the International Business Leaders Forum (IBLF)
Telephone number: +44 (0)20 7467 3659;